Showing all 4 results
Anastrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Anastrozole USP/Ph.Eur. 1 mg The Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers. Exemestane Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the potent steroidal antineoplastic agent.
Active Ingredient Strength Primary Clinical Function Exemestane USP/Ph.Eur. 25 mg Global Adult Oncology Standard: The definitive daily maintenance dose required to maintain absolute, continuous destruction of peripheral aromatase enzymes and keep estrogen levels crashed. Excipients Mannitol / Copovidone / Crospovidone / Sodium Starch Glycolate / Magnesium Stearate / Premium Polymeric Film Diluent / High-Shear Binder / Superdisintegrant / Surfactant / Heavy Film-Coating (Engineered specifically to lock the highly potent, teratogenic steroidal API safely inside the tablet, completely preventing handler and pharmacist exposure to the hazardous dust) *Pack Sizes: 10×10 Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic oncology dispensing regimens).
Tamoxifen citrate Tablets
FreeA Tamoxifen citrate tablet is a selective estrogen receptor modulator (SERM) typically prescribed for the treatment and prevention of hormone receptor-positive breast cancer.
Tamoxifen Tablet
FreeA Tamoxifen tablet is a hormone-based medication used primarily to treat and prevent hormone receptor-positive breast cancer. It belongs to a class of drugs known as selective estrogen receptor modulators (SERMs)
